ArticleCancer medicine2024

Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.

Agostina Stradella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.